Ask AI

HER2 Horizons: Bridging Innovation and Practice in HER2-Positive NSCLC Treatment

Enhance your ability to accurately identify and manage HER2-overexpressing NSCLC by integrating emerging data on HER2-directed therapies and evidence-based strategies to improve patient care through a certified interactive case challenge, expert-written ClinicalThought commentary, and downloadable slides.

Share

Program Content

Events

Activities

HER2 Positive NSCLC
HER2-Positive NSCLC Treatment
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: June 23, 2026

Supporters

This activity is supported by educational grants from AstraZeneca and Daiichi Sankyo, Inc.

AstraZeneca

Daiichi Sankyo, Inc.